Evidence map›Paper›PMID 41518385›Full record

ArticleArchives of gynecology and obstetrics2026

App supporting surveillance for (likely) pathogenic TP53 variant carriers: acceptance among a German cohort.

Juliane Nees, Senta Kiermeier, Farina Silchmueller, Myriam Keymling, Christian P Kratz, Imad Maatouk, Sarah Schott

Abstract read
In one paragraph

Article in Archives of gynecology and obstetrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Juliane NeesDepartment of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany. Juliane.Nees@kse-hd.de.ORCID 0000-0003-4886-9808
Senta KiermeierDepartment of Internal Medicine II, Chair of Integrated Psychosomatic Medicine and Psychotherapy, Julius-Maximilian University Würzburg, Würzburg, Germany.ORCID 0000-0002-5815-5713
Farina SilchmuellerPediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.ORCID 0000-0001-7712-1300
Myriam KeymlingDivision of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0002-4447-5636
Christian P KratzPediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.ORCID 0000-0003-4120-5873
Imad MaatoukDepartment of Internal Medicine II, Chair of Integrated Psychosomatic Medicine and Psychotherapy, Julius-Maximilian University Würzburg, Würzburg, Germany.ORCID 0000-0002-8030-1182
Sarah SchottDepartment of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.ORCID 0000-0002-1714-1147

Funding

Bundesministerium für Bildung und Forschung, Federal Ministry of education and research, BMBF 01GM1909ABundesministerium für Bildung und Forschung, Federal Ministry of education and research, BMBF 01GM1909DDeutsche Kinderkrebsstiftung DKS2019.13Medizinischen Fakultät Heidelberg, Universität Heidelberg Rahel-Goitein-Strauss fellowship
6 · The paper itself

Abstract

The rapid digitalization of healthcare is transforming medical care strategies. Individuals carrying (likely) pathogenic TP53 germline variants (P/LP TP53) require complex surveillance protocols. To support these individuals, we provided the adapted PatientConcept app to adults with a P/LP TP53 variant and their relatives. We analyzed the value of this adapted app for this cohort, as well as general aspects of Internet use, web-based healthcare options, mental and physical health, and fear of progression. (FOP). From a larger study consisting of 70 carriers and 43 relatives, 25 affected individuals and no relatives installed the app. App users tended to be younger and physically fitter but reported higher levels of psychological distress and FOP compared to non-users. Users rated their distress as high and expressed interest in an on-demand intervention tool offering concise information sessions. Overall, users were satisfied with the app, finding it useful and easy to understand, though they identified areas for improvement. Many app features were underutilized, indicating a need for further adaptation to the target group. Most users obtained medical information online, considering it helpful but often unreliable and difficult to evaluate. Nevertheless, app users felt confident in their ability to use the Internet for health-related search. Our study demonstrates the feasibility and acceptance of an app for individuals with LFS, supporting their surveillance and health behaviors.

Indexed as

Li-Fraumeni SyndromeMobile ApplicationsPatient Acceptance of Health CareTumor Suppressor Protein p53AdultAgedCohort StudiesFemaleGermanyGerm-Line MutationHeterozygoteHumansInternetMaleMiddle AgedYoung AdultTumor Suppressor Protein p53Cancer preventioneHealthFear of progressionLi–Fraumeni syndromeSurveillance

Identifiers

PMID41518385
PMCPMC12790533

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.